These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 8648610)
1. Inhibitors of acyl CoA:cholesterol acyltransferase. Vaccaro W; Amore C; Berger J; Burrier R; Clader J; Davis H; Domalski M; Fevig T; Salisbury B; Sher R J Med Chem; 1996 Apr; 39(8):1704-19. PubMed ID: 8648610 [TBL] [Abstract][Full Text] [Related]
2. Acyl-CoA:Cholesterol O-acyltransferase (ACAT) inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT. Astles PC; Ashton MJ; Bridge AW; Harris NV; Hart TW; Parrott DP; Porter B; Riddell D; Smith C; Williams RJ J Med Chem; 1996 Mar; 39(7):1423-32. PubMed ID: 8691472 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives. O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430 [TBL] [Abstract][Full Text] [Related]
4. Potent inhibitors of acyl-CoA:cholesterol acyltransferase. 2. Structure-activity relationships of novel N-(2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)amides. Kataoka K; Shiota T; Takeyasu T; Minoshima T; Watanabe K; Tanaka H; Mochizuki T; Taneda K; Ota M; Tanabe H; Yamaguchi H J Med Chem; 1996 Mar; 39(6):1262-70. PubMed ID: 8632433 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship studies on a novel series of naphthylidinoylureas as inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT). Ohnuma S; Muraoka M; Ioriya K; Ohashi N Bioorg Med Chem Lett; 2004 Mar; 14(5):1309-11. PubMed ID: 14980688 [TBL] [Abstract][Full Text] [Related]
6. Acyl-CoA : cholesterol acyltransferase inhibitors from Magnolia obovata. Kwon BM; Kim MK; Lee SH; Kim JA; Lee IR; Kim YK; Bok SH Planta Med; 1997 Dec; 63(6):550-1. PubMed ID: 9434609 [TBL] [Abstract][Full Text] [Related]
7. 2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus. Clader JW; Burnett DA; Caplen MA; Domalski MS; Dugar S; Vaccaro W; Sher R; Browne ME; Zhao H; Burrier RE; Salisbury B; Davis HR J Med Chem; 1996 Sep; 39(19):3684-93. PubMed ID: 8809157 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA:cholesterol O-acyltransferase inhibitors. Romeo G; Salerno L; Milla P; Siracusa M; Cattel L; Russo F Pharmazie; 1999 Jan; 54(1):19-23. PubMed ID: 9987793 [TBL] [Abstract][Full Text] [Related]
9. Guineensine, an Acyl-CoA: cholesterol acyltransferase inhibitor, from the fruits of Piper longum. Lee SW; Rho MC; Nam JY; Lim EH; Kwon OE; Kim YH; Lee HS; Kim YK Planta Med; 2004 Jul; 70(7):678-9. PubMed ID: 15254860 [TBL] [Abstract][Full Text] [Related]
10. Novel 3,5-diaryl pyrazolines as human acyl-CoA:cholesterol acyltransferase inhibitors. Jeong TS; Kim KS; An S; Cho KH; Lee S; Lee WS Bioorg Med Chem Lett; 2004 Jun; 14(11):2715-7. PubMed ID: 15125920 [TBL] [Abstract][Full Text] [Related]
11. Relationships between lipophilicity and biological activities in a series of indoline-based anti-oxidative acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors. Takahashi K; Kunishiro K; Kasai M; Miike T; Kurahashi K; Shirahase H Arzneimittelforschung; 2008; 58(12):666-72. PubMed ID: 19202739 [TBL] [Abstract][Full Text] [Related]
12. Heterocyclic amides: inhibitors of acyl-CoA:cholesterol O-acyl transferase with hypocholesterolemic activity in several species and antiatherosclerotic activity in the rabbit. White AD; Purchase CF; Picard JA; Anderson MK; Mueller SB; Bocan TM; Bousley RF; Hamelehle KL; Krause BR; Lee P; Stanfield RL; Reindel JF J Med Chem; 1996 Sep; 39(20):3908-19. PubMed ID: 8831757 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor. Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773 [TBL] [Abstract][Full Text] [Related]
14. alpha-Substituted malonester amides: tools to define the relationship between ACAT inhibition and adrenal toxicity. Sliskovic DR; Picard JA; O'Brien PM; Liao P; Roark WH; Roth BD; Anderson MA; Mueller SB; Bocan TM; Bousley RF; Hamelehle KL; Homan R; Reindel JF; Stanfield RL; Turluck D; Krause BR J Med Chem; 1998 Feb; 41(5):682-90. PubMed ID: 9513596 [TBL] [Abstract][Full Text] [Related]